A Study of LY3084077 in Healthy Participants

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The main purpose of this study is to evaluate the safety and tolerability of the study drug known as LY3084077 in healthy participants. The study will also investigate how much of the study drug gets into the blood stream and how long it takes the body to get rid of it. Information about any side effects that may occur will also be collected. The study is expected to last approximately 8 weeks for each participant.
Epistemonikos ID: a1a19e710bb5af3f6b4706ceed7968fb2c42aa17
First added on: May 11, 2024